IDS 2013* Carol Soppe
Immune Tolerance Network, CA, United States
Presentations this author is a contributor to:
Lymphocyte changes during alefacept treatment in newly diagnosed Type 1 diabetes (#15)
2:35 PM
Mark R Rigby
CLINICAL RESEARCH